Product Name: Gilteritinib (ASP2215)
 CAT#: A-1371

Request Gilteritinib (ASP2215)
 Synonym:Gilteritinib (ASP2215),

Gilteritinib Chemical Structure
Gilteritinib/I-BET-726 chemical structure


5 stars, based on 1836 reviews

IUPAC/Chemical name:

Price of Gilteritinib

We offer a substantial discount on larger orders,
please inquire via
sales@activebiochem.com
or Fax: 1-201-884-1288 (USA Fax#)


Biological Activity
Gilteritinib, also known as (ASP2215, is a potent FLT3/AXL inhibitor, which showed potent antileukemic activity against AML with either or both FLT3-ITD and FLT3-D835 mutations. In invitro, among the 78 tyrosine kinases tested, ASP2215 inhibited FLT3, LTK, ALK, and AXL kinases by over 50% at 1 nM with an IC50 value of 0.29 nM for FLT3, approximately 800-fold more potent than for c-KIT, the inhibition of which is linked to a potential risk of myelosuppression. ASP2215 inhibited the growth of MV4-11 cells, which harbor FLT3-ITD, with an IC50 value of 0.92 nM, accompanied with inhibition of pFLT3, pAKT, pSTAT5, pERK, and pS6. ASP2215 decreased tumor burden in bone marrow and prolonged the survival of mice intravenously transplanted with MV4-11 cells. ASP2215 may have potential use in treating AML.
Technical Data

Mol. Formula: C29H44N8O3
MW: 552.71
CAS#: 1254053-43-4 (Gilteritinib), 1254053-84-3 (Gilteritinib hemifumarate)
Purity: >99%
Chiral Purity: 100%
Gilteritinib MSDS Gilteritinib CoA

Reference







Purchase(buy) inhibitor Gilteritinib at Active Biochem and the United State(U.S.), Germany, Japan, France,United Kingdom(UK),Switzerland, Australia distributors.